FDA approves Medtronic’s adaptive DBS system for Parkinson’s
The U.S. Food and Drug Administration (FDA) approved Medtronic’s BrainSense adaptive deep brain stimulation (DBS) system and electrode identifier…
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
The U.S. Food and Drug Administration (FDA) approved Medtronic’s BrainSense adaptive deep brain stimulation (DBS) system and electrode identifier…
Gene enhancers may play an important role in neuronal development and neurological conditions such as Parkinson’s disease, a study…
Supernus Pharmaceuticals is on track to make Onapgo (apomorphine hydrochloride) — its newly approved medication for treating motor fluctuations…
People with tremor-dominant Parkinson’s disease experience a higher burden of nonmotor symptoms than people with essential tremor (ET),…
The diabetes medication exenatide did not slow motor symptom progression in treated Parkinson’s patients relative to those given…
A study found a link between the likely presence of REM sleep behavior disorder (RBD) in people with Parkinson’s…
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) for the continuous treatment of motor fluctuations…
Several promising strategies for developing therapeutics capable of crossing or bypassing the blood-brain barrier (BBB) offer potential for treating neurological…
Treatment with the anti-seizure medication levetiracetam led to a worsening of Parkinson’s disease symptoms for a woman in Saudi…
Blood levels of the fibronectin protein could be used as a predictor of disability in people with Parkinson’s disease,…
Get regular updates to your inbox.